Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
2024 US Election
US Politics
NFL
Donald Trump
US Economy
Joe Biden
TikTok
Republican Party
Senate
US Crime
Baseball
US Social Issues
Get access to our best features
Get Started
Published 11 months ago

Grail says about 400 patients incorrectly informed they may have cancer

Summary by Reuters
Cancer test maker Grail Inc (GRAL.O) said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.

0 Articles

All
Left
Center
Right
ReutersReuters

Grail says about 400 patients incorrectly informed they may have cancer

Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.

11 months ago·United Kingdom
Read Full Article
The Globe & MailThe Globe & Mail

Grail says over 400 patients incorrectly informed they may have cancer

Grail’s flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear

11 months ago·Canada
Read Full Article
ForbesForbes

Around 400 Grail Patients Mistakenly Told They Might Have Cancer—Company Blames Vendor

The patients signed up to take Galleri, a prescription oncology detection test, and later received letters suggesting they had cancer.

11 months ago·United States
Read Full Article
Times of San DiegoTimes of San Diego

Illumina Spinoff Grail Says Vendor Error Caused 400 Patients to Be Told They Have Cancer

A building on the Illumina Campus in University City. Reuters/Mike Blake Cancer test maker Grail said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. Grail’s flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. The company, owned by San Diego-based Illumina, said the letters were mistakenly sent by P…

11 months ago·San Diego County, United States
Read Full Article
Fox BusinessFox Business

Cancer test company says vendor mistakenly sent letters to 400 patients that they may have disease

Cancer test company Grail, Inc. said Friday its telemedicine vendor had mistakenly sent form letters to about 400 patients, telling them they may have cancer.  Grail, which is owned by San Diego-based biotechnology company Illumina, told Fox News Digital that all the patients were informed immediately of the mistake and it "was in no way related to or caused by an incorrect Galleri test result," Reuters reported.  The company’s Galleri blood tes…

11 months ago·United States
Read Full Article
Financial TimesFinancial Times

More than 400 Grail patients incorrectly told they may have cancer

Life assurance customers pause review relationship with early-detection biotech.

11 months ago·London, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 86% of the sources are Center
86% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

CancerCancer
BusinessBusiness
US EconomyUS Economy
HealthHealth
MedicalMedical
San Francisco, CaliforniaSan Francisco, California
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal